Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.
复制标题

骨髓源性抑制细胞:抗癌免疫治疗的新兴靶点

DOI:
10.1186/s12943-022-01657-y
复制
发表时间:
2022-09-26
期刊:
影响因子:
37.3
通讯作者:
Wu, Kongming
Wu, Kongming
中科院分区:
医学1区
文献类型:
--
作者:
Wu, Yuze;Yi, Ming;Niu, Mengke;Mei, Qi;Wu, Kongming

文献摘要

参考文献

被引文献

相似文献

免疫检查点抑制剂(ICIS)治疗后的临床反应支持免疫治疗作为一种潜在的抗癌治疗方法。然而,很大一部分患者由于耐药或复发而无法从中受益,这很可能是由于肿瘤微环境(TME)中的多重免疫抑制细胞所致。髓系来源的抑制细胞(MDSCs)是一组异质性的病理激活的未成熟细胞,是免疫抑制网络的主要组成部分。这些细胞有效地抑制T细胞的活性,从而有助于恶性肿瘤的免疫逃逸。新的发现表明,靶向MDSCs可能成为免疫治疗的一个替代和有前途的靶点,重塑免疫抑制微环境,提高癌症免疫治疗的疗效。在这篇综述中,我们主要关注MDSCs的分类和抑制功能,以及MDSCs与其他髓系细胞之间的相互作用。我们还简要总结了针对MDSCs的治疗的最新方法。
The clinical responses observed following treatment with immune checkpoint inhibitors (ICIs) support immunotherapy as a potential anticancer treatment. However, a large proportion of patients cannot benefit from it due to resistance or relapse, which is most likely attributable to the multiple immunosuppressive cells in the tumor microenvironment (TME). Myeloid-derived suppressor cells (MDSCs), a heterogeneous array of pathologically activated immature cells, are a chief component of immunosuppressive networks. These cells potently suppress T-cell activity and thus contribute to the immune escape of malignant tumors. New findings indicate that targeting MDSCs might be an alternative and promising target for immunotherapy, reshaping the immunosuppressive microenvironment and enhancing the efficacy of cancer immunotherapy. In this review, we focus primarily on the classification and inhibitory function of MDSCs and the crosstalk between MDSCs and other myeloid cells. We also briefly summarize the latest approaches to therapies targeting MDSCs.
DOI: 10.1126/scitranslmed.abj5070
发表时间: 2021-12-15
影响因子: 17.1
作者:
Chung, Andrew W.;Anand, Kartik;Chang, Jenny C.
通讯作者: Chang, Jenny C.
DOI: 10.4049/jimmunol.166.1.678
发表时间: 2001-01-01
影响因子: 4.4
作者:
Almand, B;Clark, JI;Gabrilovich, DI
通讯作者: Gabrilovich, DI
DOI: 10.1089/thy.2015.0289
发表时间: 2016-03-01
期刊: THYROID
影响因子: 6.6
作者:
Angell, Trevor E.;Lechner, Melissa G.;Epstein, Alan L.
通讯作者: Epstein, Alan L.
DOI: 10.1158/0008-5472.can-16-0144
发表时间: 2016-10-01
期刊: Cancer research
影响因子: 11.2
作者:
Chang AL;Miska J;Wainwright DA;Dey M;Rivetta CV;Yu D;Kanojia D;Pituch KC;Qiao J;Pytel P;Han Y;Wu M;Zhang L;Horbinski CM;Ahmed AU;Lesniak MS
通讯作者: Lesniak MS
DOI: 10.1158/0008-5472.can-07-2354
发表时间: 2007-10-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Bunt, Stephanie K.;Yang, Linglin;Ostrand-Rosenberg, Suzanne
通讯作者: Ostrand-Rosenberg, Suzanne